Arcturus Therapeutics Holdings Inc. financial data

Symbol
ARCT on Nasdaq
Location
10628 Science Center Drive, Suite 250, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 574 % +42.9%
Debt-to-equity 36.2 % -29.3%
Return On Equity -28.7 % -21.7%
Return On Assets -21.1 % -35.1%
Operating Margin -80.3 % -59.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.4M shares +4.89%
Common Stock, Shares, Outstanding 27.2M shares +0.56%
Entity Public Float 603M USD -13%
Common Stock, Value, Issued 27K USD 0%
Weighted Average Number of Shares Outstanding, Basic 27.2M shares +0.47%
Weighted Average Number of Shares Outstanding, Diluted 27.2M shares +0.47%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 97.6M USD -39.2%
Research and Development Expense 132M USD -30%
General and Administrative Expense 44.4M USD -16.1%
Operating Income (Loss) -78.3M USD +2.73%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -66.7M USD -6.94%
Income Tax Expense (Benefit) -218K USD -116%
Net Income (Loss) Attributable to Parent -66.7M USD -6.49%
Earnings Per Share, Basic -2 USD/shares -4.7%
Earnings Per Share, Diluted -2 USD/shares -6.52%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 180M USD -24%
Accounts Receivable, after Allowance for Credit Loss, Current 7.95M USD -73.7%
Assets, Current 249M USD -24.7%
Property, Plant and Equipment, Net 7.42M USD -28.3%
Operating Lease, Right-of-Use Asset 23.8M USD -13.6%
Assets 282M USD -23.8%
Accounts Payable, Current 5.49M USD -45.8%
Employee-related Liabilities, Current 4.96M USD -54.3%
Accrued Liabilities, Current 19.4M USD -40.2%
Liabilities, Current 31.7M USD -54.4%
Operating Lease, Liability, Noncurrent 21.9M USD -15.9%
Other Liabilities, Noncurrent 497K USD -82.3%
Liabilities 57.8M USD -46.9%
Retained Earnings (Accumulated Deficit) -486M USD -15.9%
Stockholders' Equity Attributable to Parent 225M USD -14.2%
Liabilities and Equity 282M USD -23.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.1M USD -532%
Net Cash Provided by (Used in) Financing Activities 15.2M USD +594%
Net Cash Provided by (Used in) Investing Activities -137K USD +42.9%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 27.2M shares +0.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.1M USD -456%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 237M USD -19.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.1M USD +1144%
Deferred Tax Assets, Valuation Allowance 138M USD +26.9%
Deferred Tax Assets, Gross 145M USD +24.2%
Operating Lease, Liability 26M USD -11.7%
Payments to Acquire Property, Plant, and Equipment 137K USD -42.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -66.7M USD -6.49%
Lessee, Operating Lease, Liability, to be Paid 30.3M USD -13.5%
Property, Plant and Equipment, Gross 19.4M USD -9.15%
Operating Lease, Liability, Current 4.12M USD +20%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.13M USD -21.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.27M USD +9.62%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.28M USD -23.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.82M USD -7.5%
Deferred Tax Assets, Operating Loss Carryforwards 25.4M USD +32.7%
Unrecognized Tax Benefits 6.8M USD +88.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.94M USD +3.01%
Additional Paid in Capital 710M USD +4.32%
Share-based Payment Arrangement, Expense 27.6M USD -27.1%